Neurodegenerative disorders (NDDs) such as Alzheimer's (AD) and Parkinson's (PD) are on
the rise, robbing people of their memories and independence. While risk factors such as age …

Alzheimer's disease (AD) still prevails and continues to increase indiscriminately throughout
the 21st century, and is thus responsible for the depreciating quality of health and …

There is currently a shortage of effective therapeutic drugs for Alzheimer's disease (AD),
which is an irreversible neurodegenerative condition. The development of AD is largely …

Demyelination is a frequent yet crippling neurological disease associated with multiple
sclerosis (MS). The cuprizone (CZ) model, which causes demyelination through oxidative …

Abstract Parkinson's disease (PD), the second most common neurological ailment in the
world after Alzheimer's disease (AD), affects about 1% of those over 65 years. Exosomes …

The treatment of neurodegenerative diseases including Alzheimer's disease (AD) has
remained a burden on the pharmaceutical industry in the past decade. This topic has …

Effective treatment of brain disorders remains a tough task in medical science. Age-old brain
disorders like Parkinson's (PD) and Alzheimer's (AD) are yet to be managed effectively in …

Hepatic encephalopathy and other neurodegenerative disorders have profound implications
for extensive liver impairment, calling for new ways of treating the condition. The application …

Neurodegenerative diseases (NDDs), a global growing concern, are posing significant
social and economic challenges, making the efficient delivery of medications to the brain a …

Pomegranate (Punica granatum) seeds are famous for their rich phytochemical composition,
especially for antioxidant polyphenols. The therapeutic potential of pomegranate seeds and …